Clinical Characteristics and Outcomes of Chronic Hepatitis C (CHC) Patients Treated With Newer Direct-Acting Antiviral (DAA)-based Regimens From a Large Us Payer Perspective

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.03.1294
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Clinical Outcomes of Direct-Acting Antiviral Therapy in Patients With Compensated Hepatitis C Virus-Related Cirrhosis

Hepatoma Research
2017English

Reactivation of Herpesvirus in Patients With Hepatitis C Treated With Direct-Acting Antiviral Agents

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2016English

A Primary Care-Based Collaborative Hepatitis C Clinic: Clinical Structure and Virologic Outcomes With Direct Acting Antiviral Therapy

Open Medicine Journal
2016English

“Empirical” Retreatment of Patients With Chronic Hepatitis C Who Failed a First Direct-Acting Antiviral-Based Regimen

Journal of Hepatology
Hepatology
2017English

Make Platelet Count Great Again: Direct‐acting Antiviral Agent Therapy in Patients With Chronic Hepatitis C

Advances in Digestive Medicine
2019English

Hepatitis B Reactivation in Chronic Hepatitis C Patients Treated With Interferon or Pan-Oral Direct-Acting Antivirals

Hepatology
MedicineHepatology
2017English

Hepatitis B Reactivation and Outcomes in Persons Treated With Directly Acting Antiviral Agents Against Hepatitis C Virus: Results From ERCHIVES

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Oral Direct-Acting Antiviral Therapy for Hepatitis C

Journal of Antivirals & Antiretrovirals
2012English

Direct‐Acting Antiviral Treatment of Patients With Hepatitis C Resolves Serologic and Histopathologic Features of Autoimmune Hepatitis

Hepatology Communications
Hepatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy